why choose us

First received: August 07, 2023

Clinical Trial: A Study of Efficacy, Safety, and Tolerability of KAN-101 in People With Celiac Disease

Study Status: Completed

Recruit Status: RECRUITING

Condition: Celiac Disease

Study Type: INTERVENTIONAL


Official Title: A Phase 2a Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of KAN-101 In Participants With Celiac Disease

Brief Summary: The study goal is to evaluate the efficacy, safety, and tolerability of KAN-101 in participants with Celiac Disease (CeD)

Read more